Boyds

We started in 2005, when the development and regulatory pathways for cell and gene therapies were still being written. Since then, we’ve supported 15 novel cell and gene therapies that are now available to patients. No other consultancy can say that. If your therapy is breaking new ground, work with the people who have helped navigate these challenges before.

When the stakes are high, you need the people who can see the way forward, help you make sound decisions and adapt as things change. This is what we do. At Boyds, we help companies navigate the complexities of drug development, providing expert support across regulatory affairs, regulatory operations and publishing, medical writing, clinical operations, medical and clinical affairs, and program management. We work with organizations at every stage of development, helping them navigate uncertainty and progress their programs towards the next milestone.

Drug development is not for the faint-hearted. A safety signal changes your study. A milestone moves overnight. Geopolitics shifts the ground beneath your program. Nobody can sell you certainty. But for more than 20 years, Boyds has brought something close: experts who have seen these challenges before, working as part of your team to help develop medicines for patient benefit. We are Boyds. We are Navigators of Uncertainty.

We're not ones to show off, but since 2005 we've helped bring 15 novel cell and gene therapies from concept to patients, built strong relationships with the FDA, MHRA and EMA, and stayed embedded with clients for five, ten, or more years. Boyds. Consultants by name only.

The regulatory environment is more unpredictable than ever. Reacting isn’t a strategy. Our team tracks regulatory developments across the FDA, MHRA and EMA, helping you anticipate change and prepare your program before requirements shift — with one trusted team guiding your global regulatory strategy. Boyds. Navigators of Uncertainty.

A safety signal is the moment experience matters most. Our medical experts help you interpret the data, make informed decisions quickly and keep your program moving - or recognise when stopping is the right decision. Boyds. Navigators of Uncertainty.